Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2021 | Racial disparities in breast cancer

Erica Michelle Stringer-Reasor, MD, University of Alabama at Birmingham, Birmingham, AL, discusses disparities in treating breast cancer and clinical trial enrollment. Participation in breast cancer trials is low, with less than 10% of patients with breast cancer participating in clinical trials, and only 1-3% of black patients enrolling in clinical trials. Racial disparities additionally exist in mortality rates, with black patients having a mortality rate of 40% then white patients. Dr Stringer-Reasor also briefly discusses barriers that prevent more patients from participating in clinical trials. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.